207 related articles for article (PubMed ID: 28777108)
1. Genetics in inclusion body myositis.
Rothwell S; Lilleker JB; Lamb JA
Curr Opin Rheumatol; 2017 Nov; 29(6):639-644. PubMed ID: 28777108
[TBL] [Abstract][Full Text] [Related]
2. New Developments in the Genetics of Inclusion Body Myositis.
Britson KA; Yang SY; Lloyd TE
Curr Rheumatol Rep; 2018 Apr; 20(5):26. PubMed ID: 29611059
[TBL] [Abstract][Full Text] [Related]
3. Immune-Array Analysis in Sporadic Inclusion Body Myositis Reveals HLA-DRB1 Amino Acid Heterogeneity Across the Myositis Spectrum.
Rothwell S; Cooper RG; Lundberg IE; Gregersen PK; Hanna MG; Machado PM; Herbert MK; Pruijn GJM; Lilleker JB; Roberts M; Bowes J; Seldin MF; Vencovsky J; Danko K; Limaye V; Selva-O'Callaghan A; Platt H; Molberg Ø; Benveniste O; Radstake TRDJ; Doria A; De Bleecker J; De Paepe B; Gieger C; Meitinger T; Winkelmann J; Amos CI; Ollier WE; Padyukov L; Lee AT; Lamb JA; Chinoy H;
Arthritis Rheumatol; 2017 May; 69(5):1090-1099. PubMed ID: 28086002
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial DNA variants in inclusion body myositis characterized by deep sequencing.
Hedberg-Oldfors C; Lindgren U; Basu S; Visuttijai K; Lindberg C; Falkenberg M; Larsson Lekholm E; Oldfors A
Brain Pathol; 2021 May; 31(3):e12931. PubMed ID: 33354847
[TBL] [Abstract][Full Text] [Related]
5. High-resolution HLA-DRB1 genotyping in an Australian inclusion body myositis (s-IBM) cohort: an analysis of disease-associated alleles and diplotypes.
Rojana-udomsart A; James I; Castley A; Needham M; Scott A; Day T; Kiers L; Corbett A; Sue C; Witt C; Martinez P; Christiansen F; Mastaglia F
J Neuroimmunol; 2012 Sep; 250(1-2):77-82. PubMed ID: 22633068
[TBL] [Abstract][Full Text] [Related]
6. High-resolution HLA genotyping in inclusion body myositis refines 8.1 ancestral haplotype association to DRB1*03:01:01 and highlights pathogenic role of arginine-74 of DRβ1 chain.
Slater N; Sooda A; McLeish E; Beer K; Brusch A; Shakya R; Bundell C; James I; Chopra A; Mastaglia FL; Needham M; Coudert JD
J Autoimmun; 2024 Jan; 142():103150. PubMed ID: 38043487
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial pathology in inclusion body myositis.
Lindgren U; Roos S; Hedberg Oldfors C; Moslemi AR; Lindberg C; Oldfors A
Neuromuscul Disord; 2015 Apr; 25(4):281-8. PubMed ID: 25638290
[TBL] [Abstract][Full Text] [Related]
8. HLA-DRB1 allele and autoantibody profiles in Japanese patients with inclusion body myositis.
Oyama M; Ohnuki Y; Inoue M; Uruha A; Yamashita S; Yutani S; Tanboon J; Nakahara J; Suzuki S; Shiina T; Nishino I; Suzuki S
PLoS One; 2020; 15(8):e0237890. PubMed ID: 32810190
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of inclusion body myositis.
Greenberg SA
Curr Opin Rheumatol; 2020 Nov; 32(6):542-547. PubMed ID: 32941249
[TBL] [Abstract][Full Text] [Related]
10. Multiple mitochondrial DNA deletions in hereditary inclusion body myopathy.
Jansson M; Darin N; Kyllerman M; Martinsson T; Wahlström J; Oldfors A
Acta Neuropathol; 2000 Jul; 100(1):23-8. PubMed ID: 10912916
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory, immune, and viral aspects of inclusion-body myositis.
Dalakas MC
Neurology; 2006 Jan; 66(2 Suppl 1):S33-8. PubMed ID: 16432143
[TBL] [Abstract][Full Text] [Related]
12. An inflammatory, familial, inclusion body myositis with autoimmune features and a phenotype identical to sporadic inclusion body myositis. Studies in three families.
Sivakumar K; Semino-Mora C; Dalakas MC
Brain; 1997 Apr; 120 ( Pt 4)():653-61. PubMed ID: 9153127
[TBL] [Abstract][Full Text] [Related]
13. Frequency of autoantibodies and correlation with HLA-DRB1 genotype in sporadic inclusion body myositis (s-IBM): a population control study.
Rojana-Udomsart A; Bundell C; James I; Castley A; Martinez P; Christiansen F; Hollingsworth P; Mastaglia F
J Neuroimmunol; 2012 Aug; 249(1-2):66-70. PubMed ID: 22554526
[TBL] [Abstract][Full Text] [Related]
14. New developments in genetics of myositis.
Rothwell S; Lamb JA; Chinoy H
Curr Opin Rheumatol; 2016 Nov; 28(6):651-6. PubMed ID: 27466937
[TBL] [Abstract][Full Text] [Related]
15. Rare variants in SQSTM1 and VCP genes and risk of sporadic inclusion body myositis.
Gang Q; Bettencourt C; Machado PM; Brady S; Holton JL; Pittman AM; Hughes D; Healy E; Parton M; Hilton-Jones D; Shieh PB; Needham M; Liang C; Zanoteli E; de Camargo LV; De Paepe B; De Bleecker J; Shaibani A; Ripolone M; Violano R; Moggio M; Barohn RJ; Dimachkie MM; Mora M; Mantegazza R; Zanotti S; Singleton AB; Hanna MG; Houlden H;
Neurobiol Aging; 2016 Nov; 47():218.e1-218.e9. PubMed ID: 27594680
[TBL] [Abstract][Full Text] [Related]
16. Proteomics of rimmed vacuoles define new risk allele in inclusion body myositis.
Güttsches AK; Brady S; Krause K; Maerkens A; Uszkoreit J; Eisenacher M; Schreiner A; Galozzi S; Mertens-Rill J; Tegenthoff M; Holton JL; Harms MB; Lloyd TE; Vorgerd M; Weihl CC; Marcus K; Kley RA
Ann Neurol; 2017 Feb; 81(2):227-239. PubMed ID: 28009083
[TBL] [Abstract][Full Text] [Related]
17. Genetic advances in sporadic inclusion body myositis.
Gang Q; Bettencourt C; Houlden H; Hanna MG; Machado PM
Curr Opin Rheumatol; 2015 Nov; 27(6):586-94. PubMed ID: 26335925
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial abnormalities in inclusion-body myositis.
Oldfors A; Moslemi AR; Jonasson L; Ohlsson M; Kollberg G; Lindberg C
Neurology; 2006 Jan; 66(2 Suppl 1):S49-55. PubMed ID: 16432145
[TBL] [Abstract][Full Text] [Related]
19. Clonal restriction of T-cell receptor expression by infiltrating lymphocytes in inclusion body myositis persists over time. Studies in repeated muscle biopsies.
Amemiya K; Granger RP; Dalakas MC
Brain; 2000 Oct; 123 ( Pt 10)():2030-9. PubMed ID: 11004120
[TBL] [Abstract][Full Text] [Related]
20. Functional relevance of mitochondrial abnormalities in sporadic inclusion body myositis.
Joshi PR; Vetterke M; Hauburger A; Tacik P; Stoltenburg G; Hanisch F
J Clin Neurosci; 2014 Nov; 21(11):1959-63. PubMed ID: 25311418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
